An Open-Label Randomized International Multi-Center Phase III Study of Capecitabine (Xeloda) in Combination With Cisplatin Versus FU/Cisplatin in Patients With Advanced and/or Metastatic Gastric Cancer.
Phase of Trial: Phase III
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin; Fluorouracil
- Indications Gastric cancer
- Focus Registrational; Therapeutic Use
- Sponsors Roche
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress
- 23 Jul 2009 Planned number of patients changed from 100 to 300 as reported by Roche record.
- 04 Jun 2009 Results have been reported in the Annals of Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History